Apolipoprotein molecular variation in Moroccan Berbers: Pentanucleotide (TTTTA)n repeat in the LPA gene and APOE-C1-C2 gene cluster

Clinical Genetics

Volumn 62, Issue 3, 2002, Pages 240-244

  Harich, N ^a   Esteban, E ^b   Lopez Alomar A ^b   Chafik, A ^a   Moral, Pedro ^b  

^a FACULTÉ DES SCIENCES   (Morocco)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

APOC1; APOC2; APOE; Apolipoproteins; LPA; North Africans; Polymorphism

Indexed keywords

ADENINE; APOLIPOPROTEIN; APOLIPOPROTEIN A; APOLIPOPROTEIN C1; APOLIPOPROTEIN C2; APOLIPOPROTEIN E; THYMINE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC CODE; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NORTH AFRICA; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; RACE DIFFERENCE;

ADOLESCENT; ADULT; APOLIPOPROTEINS A; APOLIPOPROTEINS E; FEMALE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MOROCCO; REPETITIVE SEQUENCES, NUCLEIC ACID; VARIATION (GENETICS);

EID: 0036766760     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2002.620310.x     Document Type: Article

References (28)

1. Cambien F, Poirier O, Niocaud V et al. Sequence diversity in 35 candidate genes for cardiovascular disorders. Am J Hum Genet 1999: 65: 183-191.
2. Djurovic S, Berg K. Epidemiology of Lp(a) lipoprotein: its role in atherosclerotic/thrombotic disease. Clin Genet 1997: 52: 281-292.
3. Utermann G. Genetic architecture and evolution of the lipoprotein(a) trait. Curr Opin Lipidol 1999: 10: 133-141.
4. Trommsdorf M, Köchl S, Lingenhel A et al. A pentanucleotide repeat polymorphism in the 5′-control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians. J Clin Invest 1995: 96: 150-157.
5. Deprince K, McGarvey ST, McAllister AE et al. Genetic effect of two APOA repeat polymorphisms (kringle 4 and pentanucleotide repeats) on plasma Lp(a) levels in American Samoans. Hum Biol 2001: 73: 91-104.
6. Chiu L, Hamman RF, Kamboh MI. Apolipoprotein A polymorphisms and plasma lipoprotein(a) concentrations in non-Hispanic whites and Hispanics. Hum Biol 2000: 72: 821-835.
7. de Knijff P, van den Maagdenberg AM, Frants RR, Havekes LM. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipids and lipoprotein levels. Hum Mutat 1994: 4: 178-194.
8. Davignon J, Cohn JS, Mabile L, Bernier L. Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin Chim Acta 1999: 286: 115-143.
9. Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele? Ann Hum Genet 1999: 63: 301-310.
10. Fullerton SM, Clark AG, Weiss KM et al. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet 2000: 67: 881-900.
11. Nillesen WM, Smeets HJM, Van Oost BA. Human ApoCI HpaI restriction site polymorphism revealed by the polymerase chain reaction. Nucleic Acids Res 1990: 18: 3428.
12. Geisel J, Weibhaar C, Oette K. An AvaII polymorphism. in the human apolipoprotein C-II. Clin Genet 1996: 49: 163.
13. Xu Y, Berglund L, Ramakrishnan R et al. A common HpaI RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E. J Lipid Res 1999: 40: 50-58.
14. Tsai MS, Tangalos EG, Petersen RC et al. Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet 1994: 54: 643-649.
15. Nei M. Molecular Evolutionary Genetics. New York: Columbia University Press 1987.
16. Lewontin RC. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964: 49: 49-67.
17. Raymond M, Rousset F. GENEPOP: population genetics software for exact tests and ecumenicism. J Hered 1995: 86: 248-249.
18. Schneider S, Roessli D, Excoffier L. ARLEQUIN (ver. 2000). Software for population genetic data analysis. Switzerland: Genetics and Biometry Laboratory, University of Geneva.
19. Rubin J, Pearson TA, Reed RG et al. Fluorescence-based, nonradioactive method for efficient detection of the pentanucleotide repeat (TTTTA)n polymorphism in the apolipoprotein(a) gene. Clin Chem 2001: 47: 1758-1762.
20. Valveny N, Esteban E, Kandil M et al. APOE polymorphism in Spanish and Moroccan populations. Clin Genet 1997: 51: 354-356.
21. Scacchi R, Gambina G, Ruggeri M et al. Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease. Neurosci Lett 1999: 259: 33-36.
22. Valveny N. Factors de risc genètics per a la Cardiopatia Isquèmica. Polimorfismes en gens del metabolisme lipoproteïc. PhD Thesis. Barcelona: University of Barcelona 2000.
23. Seixas S, Trovoada MJ, Rocha J. Haplotype analysis of the apolipoprotein E and apolipoprotein CI loci in Portugal and Sao Tomé e Príncipe (gulf of Guinea): linkage disequilibrium evidence that APOE*4 is the ancestral APOE allele. Hum Biol 1999: 71: 1001-1008.
24. Cavalli-Sforza LL, Menozzi P, Piazza A. The History and Geography of Human Genes. New Jersey: Princeton University Press 1994.
25. Harich N, Esteban E, Chafik A et al. Classical polymorphisms in Berbers from Moyen Atlas (Morocco): genetics, geography, and historical evidence in the Mediterranean peoples. Ann Hum Biol (in press).
26. Valenti K, Aveynier E, Leauté S et al. Contribution of apolipoprotein(a) size, pentanucleotide TTTTA repeat and C/T (+93) polymorphisms of the apo(a) gene to regulation of lipoprotein(a) plasma levels in a population of young European Caucasians. Atherosclerosis 1999: 147: 17-24.
27. Volkova MV, Vasina VI, Fomicheva EV et al. Comparative analysis of apo(A) genes alleles: Distribution of pentanucleotide repeats in position - 1371 and C/T transition in position + 93 among patients with myocardial infarction and a control group in St. Petersburg, Russia. Biochem Mol Med 1997: 61: 208-213.
28. Amemiya H, Arinami T, Kikuchi S et al. Apolipoprotein(a) size and pentanucleotide repeat polymorphisms are associated with the degree of atherosclerosis in coronary heart disease. Atherosclerosis 1996: 123: 181-191.